IRD US Equity
Opus Genetics, Inc.Health Care · Pharmaceutical Preparations · CIK 1228627 · FY ends Dec 31$4.07
+0.38 (+10.30%)
USD · as of 2026-08-19 · marketstack
Short interest· FINRA consolidated · settlement 2026-07-31
6 settlement cycles| Shares short | 10.8M |
| % of shares out | 13.0% |
| Days to cover | 11.9 |
| Δ vs 2026-07-15 | +5.7% |
bars = shares short · line = days to cover (own scale)
| Settlement | Shares short | Δ vs prior | Avg daily volume | Days to cover |
|---|
| 2026-07-31 | 10,848,529 | +5.7% | 908,931 | 11.9 |
| 2026-07-15 | 10,265,963 | +24.8% | 820,063 | 12.5 |
| 2026-06-30 | 8,228,353 | +43.4% | 1,568,617 | 5.3 |
| 2026-06-15 | 5,737,860 | +46.5% | 806,434 | 7.1 |
| 2026-05-29 | 3,917,871 | +26.0% | 807,581 | 4.8 |
| 2026-05-15 | 3,109,049 | +55.5% | 971,585 | 3.2 |
FINRA Rule 4560 · twice monthly, published ~a week later.
Output of a disclosed model — assumptions may be wrong. Research, not investment advice. See the Disclaimer.
